https://scholars.lib.ntu.edu.tw/handle/123456789/529087
標題: | Risk factors and management for anastomotic stricture after surgical reconstruction of esophageal atresia | 作者: | Chiang C.-M. WEN-MING HSU Chang M.-H. HONG-YUAN HSU YEN-HSUAN NI HUEY-LING CHEN JIA-FENG WU |
公開日期: | 2021 | 出版社: | Elsevier B.V. | 卷: | 120 | 期: | 1 | 起(迄)頁: | 404-410 | 來源出版物: | Journal of the Formosan Medical Association | 摘要: | Background/purpose: Anastomotic stricture (AS) is a major morbidity of patients with esophageal atresia (EA) after surgical reconstruction. Our study determined the risk factors of AS after EA reconstruction. The therapeutic efficacy and complications of esophageal dilatation for children with AS were also evaluated. Methods: Forty children treated for EA between January 2008 and December 2018 were included in this retrospective analysis. Esophageal dilatation was performed when AS was diagnosed. The therapeutic effect of esophageal dilatation was determined based on nutritional status, as assessed by the weight-for-age z-score. Results: Sixteen EA patients developed AS. A gap >1.5 cm between the esophageal pouches (P = 0.02) in patients with EA and type A EA was a risk factor for developing AS. A mean of 7.7 sessions of esophageal dilatation were performed per patient, and no complications occurred. The nutritional status of EA children with AS after dilatation was not inferior to that of the children without AS at the 6-month follow-up. Conclusion: A gap >1.5 cm between the esophageal pouches and type A EA are risk factors for AS after esophageal reconstruction. Esophageal dilatation is both safe and effective for managing strictures and improves nutritional status in EA children with AS. © 2020 |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086721230&doi=10.1016%2fj.jfma.2020.06.020&partnerID=40&md5=d5a0face6db0184994105f7859b918f0 https://scholars.lib.ntu.edu.tw/handle/123456789/529087 |
ISSN: | 0929-6646 | DOI: | 10.1016/j.jfma.2020.06.020 | SDG/關鍵字: | cephalosporin; contrast medium; histamine H2 receptor antagonist; proton pump inhibitor; anastomosis stenosis; Article; aspiration pneumonia; balloon dilatation; child; child nutrition; clinical article; clinical effectiveness; computer assisted tomography; controlled study; data analysis software; diagnostic accuracy; dysphagia; esophagus atresia; esophagus dilatation; esophagus reconstruction; esophagus stenosis; female; follow up; gastrostomy; human; male; malnutrition; nutritional status; patient safety; pediatric surgery; prematurity; receiver operating characteristic; reflux esophagitis; retrospective study; risk factor; school child; sensitivity and specificity; sex difference; underweight; vomiting; adverse event; anastomosis; esophagus stenosis; postoperative complication; risk factor; stenosis, occlusion and obstruction; treatment outcome; Anastomosis, Surgical; Constriction, Pathologic; Esophageal Atresia; Esophageal Stenosis; Humans; Postoperative Complications; Retrospective Studies; Risk Factors; Treatment Outcome |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。